相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Omission of day+11 methotrexate dose and allogeneic hematopoietic cell transplantation outcomes: results of a systematic review/meta-analysis
Mohamed A. Kharfan-Dabaja et al.
BONE MARROW TRANSPLANTATION (2022)
Efficacy of folinic acid rescue following MTX GVHD prophylaxis: results of a double-blind, randomized, controlled study
Moshe Yeshurun et al.
BLOOD ADVANCES (2020)
Adverse events in second- and third-line treatments for acute and chronic graft-versus-host disease: systematic review
Vladica M. Velickovic et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2020)
Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation
Saurabh Chhabra et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation
Betty K. Hamilton et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy
Robert Zeiser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Substitution of methotrexate with corticosteroid for acute graft-versus-host disease prevention in transplanted patients who develop methotrexate toxicity
Sung-Yong Kim et al.
ANNALS OF HEMATOLOGY (2016)
Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantation
Betty K. Hamilton et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
How we treat chronic graft-versus-host disease
Mary E. D. Flowers et al.
BLOOD (2015)
Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation
Philippe Armand et al.
BLOOD (2014)
Omission of day-11 MTX, in combination with tacrolimus, is not associated with increased risk of acute graft-versus-host disease after allo-BMT
A. Honda et al.
BONE MARROW TRANSPLANTATION (2013)
A Randomized Phase II Trial Comparing Tacrolimus and Mycophenolate Mofetil to Tacrolimus and Methotrexate for Acute Graft-versus-Host Disease Prophylaxis
Janelle Perkins et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Reduced-Intensity Conditioning Regimen Workshop: Defining the Dose Spectrum. Report of a Workshop Convened by the Center for International Blood and Marrow Transplant Research
Sergio Giralt et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Mycophenolate mofetil combined with tacrolimus and minidose methotrexate after unrelated donor bone marrow transplantation with reduced-intensity conditioning
Chisaki Mizumoto et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2009)
T cell-depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin
Ann A. Jakubowski et al.
BLOOD (2007)
Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure
Joseph H. Chewning et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Individual patient data meta-analysis of allogeneic peripheral blood stem cell transplant vs bone marrow transplant in the management of hematological malignancies: indirect assessment of the effect of day 11 methotrexate administration
W. Bensinger
BONE MARROW TRANSPLANTATION (2006)
Twenty-year follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host-disease in patients administered HLA-identical marrow grafts for leukemia
ML Sorror et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation
B Bolwell et al.
BONE MARROW TRANSPLANTATION (2004)
Omission of day+11 methotrexate after allogeneic bone marrow transplantation is associated with increased risk of severe acute graft-versus-host disease
S Kumar et al.
BONE MARROW TRANSPLANTATION (2002)
分享论文
